HepaPredict AB
559057-7044ActiveSpecialized CRO using 3D liver spheroids for drug toxicity prediction.
Contract Research Organization (CRO)hepapredict.com
Oversigt
- 1–4
- Medarbejdere
- 1–2.5mio SEK
- Omsætning
- 2016
- Grundlagt
Nøglebeslutningstagere
Volker Lauschke
Co-founder and CEO
@hepapredict.com+46707XXXXXX
Magnus Ingelman-Sundberg
Co-founder and Chairman of the Board
@hepapredict.com
Bo Qwarnström
Member of the Board
@hepapredict.com
Sabine U. Vorrink
Chief Operating Officer (COO)
Beskrivelse
HepaPredict AB is a specialized Contract Research Organization (CRO) founded in 2016 as a spin-off from Karolinska Institutet. The company focuses intensely on drug metabolism, toxicity assessment, and drug development services specifically related to liver diseases. Their primary offering revolves...